Medtronic Closes €3.0B Public Offering of Senior Notes

Medtronic Closes €3.0B Public Offering of Senior Notes

Client News

Related Solutions

Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.

On June 3, 2024, Medtronic, Inc., a wholly-owned indirect subsidiary of Medtronic plc, the leading global healthcare technology company, announced the closing of its recent public offering of €850 million aggregate principal amount of 3.650% Senior Notes due 2029, €850 million aggregate principal amount of 3.875% Senior Notes due 2036, €600 million aggregate principal amount of 4.150% Senior Notes due 2043 and €700 million aggregate principal amount of 4.150% Senior Notes due 2053. Medtronic expects to use net proceeds from the offering for general corporate purposes, which may include the repayment of outstanding commercial paper and other indebtedness.

The WilmerHale team advising Medtronic was led by Justin Ochs and Craig Hilts, and included Andrew Langworthy, Sarah Matchett and Emily Ivers, with assistance from Julie Hogan Rodgers and Ben Kelsey (Tax), Timothy Silva and Ben Lobley (Investment Management) and Heidi Treiber (Corporate).

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel